Sommetrics
Sommetrics is a private San Diego medical device company developing aer+ (continuous negative external pressure) products — including aerSleep for obstructive sleep apnea and aerFree for sedation airway management — targeting CPAP-intolerant patients and acute care procedural settings through distributor partnerships.
- Company typePrivate
- Founded2010
- HeadquartersVista, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Sommetrics does
Sommetrics is a private medical device company headquartered in San Diego, California, founded in 2010 by Dr. Richard Rose and Jerry Aarestad (originally incorporated as 5i Sciences, rebranded in November 2014). The company develops products based on its proprietary aer+ technology — also referred to as continuous negative external pressure (cNEP) — which applies mild vacuum externally to the neck via a soft silicone collar to hold the upper airway open during sleep or sedation. Its product portfolio includes aerSleep II (investigational second-generation device for moderate-to-severe obstructive sleep apnea in CPAP-intolerant patients, currently in pivotal SUPRA trial with FDA Breakthrough Device designation), aerSleep I (first-generation device with Health Canada approval), and the aerFree Airway Management System (FDA-cleared for maintaining upper airway patency during mild to moderate sedation). The technology is protected by 33 issued patents globally.
The company operates a distributor-led business model. aerFree is commercialized through Smiths Medical in select U.S. markets with planned global expansion, while aerSleep I is distributed in Canada through AvantSleep. aerSleep II is currently provided directly to clinical trial subjects at approximately 10 U.S. university and community-based sleep centers. Sommetrics has raised approximately $31M+ cumulatively across Series B, Series B-1, and Series C Preferred financings, with the most recent $11M round (targeting $16M) closed in September 2021 to fund the pivotal trial and commercial launch readiness. The company is led by founder/CEO Dr. Richard Rose and has accumulated ISO 13485:2016 certification, FDA Breakthrough Device designation, and an advisory board that includes the inventor of CPAP.
Sommetrics firmographics
Firmographics- Name
- Sommetrics
- Legal name
- Sommetrics, Inc.
- Website
- https://sommetrics.com
- Company type
- Private
- Founded year
- 2010
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Sommetrics is a private San Diego medical device company developing aer+ (continuous negative external pressure) products — including aerSleep for obstructive sleep apnea and aerFree for sedation airway management — targeting CPAP-intolerant patients and acute care procedural settings through distributor partnerships.
- Ownership category
- akta.pro rank
Sommetrics industry classification
Industry- Product category
- Sleep Apnea Medical Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Sleep Apnea Therapy Devices (CPAP/APAP/BiPAP/ASV) (HLAHAGAA)
- akta.pro secondary industries
- Respiratory & Sleep Therapy Equipment (Oxygen, CPAP/BiPAP, Nebulizers) (HSABAKAD), Airway Management Devices (ET Tubes, LMAs, Tracheostomy, Suction) (HLAHAGAF), Noninvasive Ventilation Interfaces & Consumables (Masks, Tubing, Humidifiers, Filters) (HLAHAGAG)
Keywords
Where Sommetrics is headquartered
LocationHeadquarters
- HQ city
- Vista
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Sommetrics business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Operations, Personnel, Marketing or Sales, Supply Chain
Revenue model
- Medical Device Sales: Sommetrics generates revenue through the sale of its medical devices including the aerSleep system for sleep apnea treatment and aerFree system for acute care airway management. The company has received Health Canada approval for aerSleep I and FDA clearance for aerFree. Revenue model involves hardware sales through distribution partners and direct channels.
- Series C Preferred Financing: The company raised $11 million in Series C Preferred financing with up to $16 million targeted for the round. Funds support pivotal trial and commercial launch readiness. This is capital raising, not operational revenue.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels7 records
Sommetrics product offering
Product offeringCore offering
Sommetrics develops and commercializes medical devices based on its proprietary aer+ (cNEP - Continuous Negative External Pressure) technology, which applies mild external vacuum to the neck via a soft silicone collar to keep the upper airway open. Its core products are the aerSleep system for treating obstructive sleep apnea (OSA) in CPAP-intolerant patients and the aerFree Airway Management System for maintaining airway patency during medical procedures under mild to moderate sedation.
Product overview
Sommetrics offers a portfolio of medical devices based on its proprietary aer+ technology (formerly cNEP - Continuous Negative External Pressure), which applies external vacuum to the neck to hold the upper airway open during sleep or medical procedures. The core product line consists of: aerSleep II (second-generation prescription sleep apnea device currently in pivotal trial), aerSleep I (first-generation sleep apnea device with Health Canada approval), and aerFree AMS (acute care airway management device FDA-cleared for procedural sedation). The technology is protected by 36 issued patents.
Differentiator
Problem solved
Functional benefit
Brands
- aer+ technology: Proprietary continuous negative external pressure (cNEP) technology used in Sommetrics products to keep the upper airway open during sleep.
- aerSleep
- aerFree
Products and services
- aerSleep II Self-contained wearable medical device that applies mild external vacuum (negative pressure) to the neck via a soft silicone collar with integrated silent piezoelectric pump to hold the upper airway open during sleep, designed for treatment of moderate to severe obstructive sleep apnea in patients unable to tolerate CPAP therapy. Investigational device currently in pivotal SUPRA trial.
- aerSleep (aerSleep I) First generation sleep apnea device using continuous negative external pressure (aer+ technology/cNEP) to treat obstructive sleep apnea. Health Canada Medical Device License approved; served as basis for FDA Breakthrough Device designation of aerSleep II.
- aerFree Airway Management System (AMS) FDA-cleared and CE-marked acute care device that applies external negative pressure to maintain upper airway patency during mild to moderate sedation in medical procedures. First FDA-cleared external negative pressure aid for this indication, distributed by Smiths Medical to hospitals and ambulatory surgery centers.
Quantifiable outcome
- AHI reduced from 27.5 to 8.7 in initial responders; to 6.9 after 6 months of home use
- +4 more outcomes
Companies that use Sommetrics
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles2 records
Sommetrics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Sommetrics partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and minor.
- AvantSleepcoreSommetrics partnered with AvantSleep to distribute aerSleep in Canada following Health Canada approval. AvantSleep distributes aerSleep in select Canadian markets, followed by a full Canadian launch in 2018.
- Smiths MedicalcoreSmiths Medical, a leading global medical device manufacturer, signed a distribution partnership with Sommetrics to distribute the aerFree Airway Management System (AMS). As part of the partnership, Smiths Medical distributes aerFree AMS in select U.S. markets, followed by a global launch in 2018. aerFree is the first FDA-cleared external negative pressure aid that maintains a patent upper airway during mild to moderate sedation.
- Scripps Green Hospital and Scripps Clinic Torrey PinesminorClinical research partnership for landmark cNEP Airway study. The 54-patient study was conducted at the Division of Gastroenterology and Hepatology at Scripps Green Hospital and Scripps Clinic Torrey Pines in La Jolla, demonstrating 45% reduction in respiratory impairment during colonoscopy.
Scale indicators8 records
Recent moves6 records
Expansion highlights5 records
Sommetrics competitors and assessment
Company assessmentBroad incumbents
- ResMed: Global leader in CPAP/APAP devices and masks for sleep apnea. Direct incumbent in OSA treatment with multi-billion dollar sales and the dominant U.S. payer contracts Sommetrics would need to compete against.
- Philips Respironics: Major CPAP/BiPAP manufacturer and sleep-disordered breathing solutions provider. A direct incumbent competitor in the OSA device market that Sommetrics would need to displace or differentiate against.
- Fisher & Paykel Healthcare: Manufacturer of CPAP devices, nasal masks, and respiratory care products. Directly competes with Sommetrics in the OSA therapy market and is a global leader in hospital and home respiratory care.
- Inogen: Manufacturer of portable oxygen concentrators for respiratory patients. Operates in the broader home respiratory care space overlapping with Sommetrics' channel and customer base; Sommetrics board includes Inogen's former CEO.
Direct peers
- Inspire Medical Systems: Developer of an implantable neurostimulation system for moderate-to-severe OSA patients who cannot tolerate CPAP. Targets the same CPAP-intolerant patient population with a different mechanism of action; comparable regulatory and commercialization pathway.
Emerging players
- Nyxoah: Belgium-based developer of a hypoglossal nerve stimulation system for OSA. Competes for the same CPAP-intolerant OSA patient population with a novel implantable approach; meaningful but partial overlap in clinical and commercial positioning.
- ApniCure: Developed an external negative-pressure oral appliance (Winx) for sleep apnea using a similar mechanism of action to Sommetrics' cNEP approach. Closest direct functional comparator to aerSleep, though it historically struggled commercially.
- Itamar Medical: Developer of home sleep apnea diagnostic devices (WatchPAT) and respiratory/cardiovascular monitoring solutions. Comparable as a focused sleep-disordered-breathing medical device company; complementary rather than directly competitive.
- Ai/Airway Management Inc. Manufacturer of oral appliances and alternatives for sleep apnea and snoring. Targets the same CPAP-intolerant patient segment with mandibular advancement devices; partial direct competitor in alternative OSA therapy.
- BMC Medical: China-based manufacturer of CPAP, BiPAP, and respiratory care devices with growing global presence. Competes with Sommetrics in sleep apnea therapy hardware with a broader product portfolio and cost-advantaged manufacturing.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks7 records
Key highlights7 records
Customer concentration
Sommetrics social profiles
Digital presenceSommetrics compliance and trust
Trust signalCompliance4 records
Sommetrics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Sommetrics leadership team
Management profileNumber of profiles
Profiles9 records
Sommetrics funding detail
Funding detailFunding overview
Funding rounds4 records
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Sommetrics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Sommetrics
What does Sommetrics do?
Sommetrics develops and commercializes medical devices based on its proprietary aer+ (cNEP - Continuous Negative External Pressure) technology, which applies mild external vacuum to the neck via a soft silicone collar to keep the upper airway open. Its core products are the aerSleep system for treating obstructive sleep apnea (OSA) in CPAP-intolerant patients and the aerFree Airway Management System for maintaining airway patency during medical procedures under mild to moderate sedation.
Is Sommetrics a public or private company?
Sommetrics is a private company. It is classified as venture growth investor backed and is currently operating.
When was Sommetrics founded?
Sommetrics was founded in 2010. It employs 11 to 50 people.
Where is Sommetrics based?
Sommetrics is headquartered in Vista, United States, in the North America region.
How does Sommetrics make money?
Two revenue lines are on record. Medical Device Sales are the primary driver. The others are series C Preferred Financing.
Who are Sommetrics's main competitors?
Broad incumbents on record are ResMed, Philips Respironics, Fisher & Paykel Healthcare and Inogen. Inspire Medical Systems is listed as a direct peer. Emerging players are Nyxoah, ApniCure, Itamar Medical, Ai/Airway Management Inc. and BMC Medical.
Does Sommetrics have an API?
No public API is recorded for Sommetrics.
What industry is Sommetrics in?
Sommetrics's product category is Sleep Apnea Medical Devices. Its primary akta.pro industry code is HLAHAGAA, Sleep Apnea Therapy Devices (CPAP/APAP/BiPAP/ASV), with a secondary code of HSABAKAD, Respiratory & Sleep Therapy Equipment (Oxygen, CPAP/BiPAP, Nebulizers). Its NAICS code is 334510 and its SIC code is 3841.